EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study

Renan Galuzo iD, Thiago Lazari Machado, Ryann de Souza Nascimento, Jorvan Ramos de Medeiros, Luciana Neves Tubarão, Jane Silva, Vanessa Pimenta Rocha, Tamiris Azamor, Felipe Soares Coelho, Andrea Marques Vieira da Silva iD, Lorenna Carvalho da Rosa iD, Juliana Fernandes Amorim da Silva iD und 6 weitere

Viruses · 2025

DOI: 10.3390/v17091233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Renan Galuzo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Hauptthemen laut MEDLINE: Lectins, C-Type, Monocytes, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Oswaldo Cruz, Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro - FAPERJ.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

CLEC5A is a C-type lectin expressed by monocytes and neutrophils, playing an important role in innate immunity. Although it has been shown to interact with the spike protein of SARS-CoV-2, its role during vaccination remains poorly understood.

Methods

To address this question, we combined in vitro assays to characterize CLEC5A and spike expression and their impact on monocyte differentiation and T-cell activation; in vivo studies to evaluate CLEC5A expression, immune responses, and vaccine efficacy in a murine model; and in silico analyses to identify potential spike epitopes and CLEC5A interaction sites.

Results

The Pfizer-BioNTech bivalent mRNA vaccine induced spike expression and CLEC5A upregulation in THP-1 monocytes, promoting M1-like differentiation and CD86+ activation. In PBMC co-cultures, CLEC5A+ monocytes acted as antigen-presenting cells, releasing inflammatory chemokines and activating both CD4+ and CD8+ T cells, thereby linking CLEC5A expression to adaptive immunity. In mice, CLEC5A expression was observed on inflammatory monocytes (CCR2+CX3CR1low) within two days of vaccination. In vivo, CLEC5A expression increased during SARS-CoV-2 infection and after immunization, but declined following viral challenge in vaccinated animals. Consistently, robust humoral and cellular responses were detected post-immunization. In silico analysis further suggested differential CLEC5A binding across B- and T-cell epitopes within the spike glycoprotein.

Conclusions

These findings suggest that CLEC5A may play a role in bridging innate and adaptive immune responses during SARS-CoV-2 vaccination. Although further studies with different vaccine platforms are necessary to confirm and expand these observations, our results provide preliminary evidence supporting the potential of CLEC5A as an exploratory biomarker of vaccine-induced immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lectins, C-TypeMonocytesCOVID-19SARS-CoV-2Adaptive ImmunityCOVID-19 VaccinesReceptors, Cell SurfaceAnimalsHumansMiceSpike Glycoprotein, CoronavirusFemaleVaccinationmRNA VaccinesTHP-1 CellsMice, Inbred C57BLLymphocyte ActivationVaccines, Synthetic

Stichwörter der Autor:innen

CLEC5ASARS-CoV-2animal modelsimmunitymRNA vaccine

Substanzen

Lectins, C-TypeSpike Glycoprotein, CoronavirusCLEC5A protein, humanCOVID-19 Vaccinesspike protein, SARS-CoV-2Receptors, Cell SurfacemRNA VaccinesVaccines, Synthetic

Autor:innen und Institutionen

  • Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
  • Biological Sciences Building, Kensington Campus, University of New South Wales, Sydney, NSW 2033, Australia.

ORCID-Profile: Renan Galuzo, Andrea Marques Vieira da Silva, Lorenna Carvalho da Rosa, Juliana Fernandes Amorim da Silva, Renata Tourinho Santos, Carolina Baeta Salvador Várady, Patricia Cristina da Costa Neves, Juliana Gil Melgaço

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Oswaldo Cruz
  • Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro - FAPERJ
  • Fundação Oswaldo Cruz/Ministry of Health/PAHO
  • Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro

Zitieren

APA

Galuzo, R., Lazari Machado, T., de Souza Nascimento, R., Ramos de Medeiros, J., Neves Tubarão, L., Silva, J., Pimenta Rocha, V., Azamor, T., Soares Coelho, F., da Silva, A. M. V., Carvalho da Rosa, L., da Silva, J. F. A., Santos, R. T., Müller, R., Várady, C. B. S., Ano Bom, A. P. D., Neves, P. C. D. C., & Melgaço, J. G. (2025). CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses. https://doi.org/10.3390/v17091233

Vancouver

Galuzo R, Lazari Machado T, de Souza Nascimento R, Ramos de Medeiros J, Neves Tubarão L, Silva J, et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses. 2025. doi:10.3390/v17091233

BibTeX
@article{Galuzo2025,
  author = {Galuzo, Renan and Lazari Machado, Thiago and de Souza Nascimento, Ryann and Ramos de Medeiros, Jorvan and Neves Tubarão, Luciana and Silva, Jane and Pimenta Rocha, Vanessa and Azamor, Tamiris and Soares Coelho, Felipe and da Silva, Andrea Marques Vieira and Carvalho da Rosa, Lorenna and da Silva, Juliana Fernandes Amorim and Santos, Renata Tourinho and Müller, Rodrigo and Várady, Carolina Baeta Salvador and Ano Bom, Ana Paula Dinis and Neves, Patricia Cristina da Costa and Melgaço, Juliana Gil},
  title = {CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17091233}
}
Kostenlos starten →